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Enteric glial cells (EGCs) are the main constituent of the enteric nervous system and share
similarities with astrocytes from the central nervous system including their reactivity to an
inflammatory microenvironment. Previous studies on EGC pathophysiology have specifi-
cally focused on mucosal glia activation and its contribution to mucosal inflammatory pro-
cesses observed in the gut of inflammatory bowel disease (IBD) patients. In contrast
knowledge is scarce on intestinal inflammation not locally restricted to the mucosa but sys-
temically affecting the intestine and its effect on the overall EGC network.
Methods and Results
In this study, we analyzed the biological effects of a systemic LPS-induced hyperinflamma-
tory insult on overall EGCs in a rat model in vivo, mimicking the clinical situation of systemic
inflammation response syndrome (SIRS). Tissues from small and large intestine were
removed 4 hours after systemic LPS-injection and analyzed on transcript and protein level.
Laser capture microdissection was performed to study plexus-specific gene expression
alterations. Upon systemic LPS-injection in vivo we observed a rapid and dramatic activa-
tion of Glial Fibrillary Acidic Protein (GFAP)-expressing glia on mRNA level, locally
restricted to the myenteric plexus. To study the specific role of the GFAP subpopulation, we
established flow cytometry-purified primary glial cell cultures from GFAP promotor-driven
EGFP reporter mice. After LPS stimulation, we analyzed cytokine secretion and global
gene expression profiles, which were finally implemented in a bioinformatic comparative
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transcriptome analysis. Enriched GFAP+ glial cells cultured as gliospheres secreted
increased levels of prominent inflammatory cytokines upon LPS stimulation. Additionally, a
shift in myenteric glial gene expression profile was induced that predominantly affected
genes associated with immune response.
Conclusion and Significance
Our findings identify the myenteric GFAP-expressing glial subpopulation as particularly sus-
ceptible and responsive to acute systemic inflammation of the gut wall and complement
knowledge on glial involvement in mucosal inflammation of the intestine.
Introduction
Enteric glial cells (EGCs) are the most abundant cells within the enteric nervous system (ENS).
EGCs are located adjacent to neurons within the enteric ganglia and along interganglionic con-
nectives of the myenteric and submucosal plexus, but also project into the extraganglionic
mucosal layer [1–5]. They resemble central nervous system (CNS) astrocytes in their morphol-
ogy [3,6] and in the expression of shared markers such as the intermediate filament protein
glial fibrillary acidic protein (GFAP) [7] and the calcium-binding protein S100 [8]. On a func-
tional level both glial cell types resemble in their reactivity to an inflammatory environment.
Like astrocytes [9], EGCs can exert immunomodulatory functions, they can express major
histocompatibility complex (MHC) class II molecules [10,11] and secrete inflammatory signal-
ing molecules such as interleukins IL-1β and IL-6 [12,13] as well as other mediators including
nerve growth factor (NGF), S-Nitrosoglutathione (GSNO), nitric oxide (NO) and S100B [14].
Inflammation-activated CNS astrocytes are characterized by hypertrophy and proliferation,
along with an upregulation of cytoskeletal GFAP [15]. Similarly, under inflammatory bowel
disease (IBD) conditions, gliogenesis occurs within the EGC network [16] and prominent alter-
ations in the expression levels of GFAP as well. In ulcerative colitis (UC) patient biopsies,
mucosal GFAP expression levels are significantly elevated in inflamed region whereas in
Crohn’s disease (CD) patients GFAP expression levels are lower and even significantly reduced
in non-inflamed mucosal biopsies compared to healthy controls [17,18]. Additionally, EGCs
upregulate expression of intracellular GFAP after experimental acute inflammatory stimulation
in vitro [19]. Even though this inflammation-induced increase in GFAP expression is well-
described, the pathophysiological role of the GFAP-expressing EGC-subpopulation remains
largely obscure.
So far, studies on EGC activation and GFAP upregulation have exclusively focused on
mucosal glial processes. Mucosal inflammation as in IBD occurs when the finely regulated
communication between the host mucosal immune system and the outside microbiota is dysre-
gulated at their contact site, the epithelial barrier. Glial processes in the mucosa have gained
attention since they are in intimate association with the epithelial cell layer, form a dense net-
work at the epithelial crypts and release mediators that increase intestinal barrier integrity,
potentially beneficial to counteract barrier breakdown [1,20,21,22]. However, the majority of
EGCs are located outside the mucosa in the myenteric and submucosal plexus structures. Their
activation and contribution to inflammation progression is largely unknown. Recently, it was
shown that plexus-originating glial cells continuously invade the lamina propria to form the
mucosal glial network, dependent on signals emanating from the gut microbiota [23]. These
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findings render ganglionated glial cells highly interesting for the study of inflammation-
induced alterations.
Furthermore, studies on EGC pathophysiology have previously focused on local intestinal
inflammation originating within the mucosa, and little is known about other inflammatory
conditions affecting the bowel. One such condition is the systemic inflammation response syn-
drome (SIRS) or sepsis, a life-threatening complication in clinically ill patients commonly seen
after impairment of gut motility due to surgical procedures or trauma [24]. The intestine holds
a special position in disease onset and progression, since it is both a source and target of the
infection. Local intestinal inflammation, triggered by intestinal manipulation, can lead to
release of inflammatory mediators that enter mesenteric lymph and bacterial translocation
across the epithelial barrier into the bloodstream, thereby spreading to sites distant from the
initial local inflammation [25,26]. The subsequent secondary septic infection can cause multi-
ple organ dysfunction, affecting the entire intestine and other organs.
In the present study, we investigate alterations in the glial network in a lipopolysaccharide
(LPS)-induced acute systemic inflammation rat model in vivo [27] to test if activation of EGCs
known to occur in mucosal inflammation can be observed also in a severe systemic inflamma-
tion. Indeed, we found rapid upregulation of Gfap gene expression upon intravenous LPS-
injection, however specifically confined to the myenteric plexus.
To further characterize this GFAP-expressing myenteric glial subpopulation, we conducted
an in vitro study with purified primary murine GFAP-EGCs cultured as gliospheres. Microar-
ray and proteomics analysis of LPS-stimulated gliospheres confirmed specific molecular associ-
ation of myenteric GFAP-glia with immunologic processes. Taken together, our study
underlines the pivotal role of myenteric glia during acute gut inflammation and sepsis.
Materials and Methods
Animal Research was approved by the Ethics Committee of the District of Unterfranken,
Wuerzburg, Germany. Approval number: 48/10
Rat animal model of hyperinflammation
Rats were employed for the hyperinflammation model because the downscaling of the elabo-
rate intensive care setup, usually employed for human patients, was feasible to the size of rats
but not of mice. Upon animal care committee approval 10 male Sprague Dawley rats (mean
weight: 0.330±0.025 kg) were obtained from Harlan Winkelmann (NMHorst, Netherlands)
and kept on a standard diet and water ad libitum at 12 h day and night cycles. Hyperinflamma-
tion was induced as previously described [27,28]. Briefly, a continuous intensive care set-up
was chosen to closely monitor temperature and macrohemodynamic changes. Animals were
anaesthetized using isoflurane 1.5–2.5% (v/v) (Forene, Abbott, Wiesbaden, Germany)–nitrous
oxide inhalation 50% v/v (Forene, Abbott) and anaesthesia was deepened during the procedure
using 0.7% (v/v) isoflurane with a continuous intravenous application of fentanyl and midazo-
lam (Midazolam-ratiopharm, Ratiopharm, Ulm, Germany) discontinuing the nitrous oxide.
Rats were randomized into a control and a LPS-treated group, n = 5 each. Control animals
received a 0.5 ml intravenous bolus of NaCl as placebo, whereas Lipopolysaccharide (LPS; E.
coli O111:B4, Sigma Aldrich, Deisenhofen, Germany; potency 3 EU/ng) was applied intrave-
nously at a concentration of 2.5 mg/kg in the LPS group. After 3.5 h, laparotomy was per-
formed and 4 h after the LPS-injection animals were sacrificed via overdose of isoflurane. Gut
tissue samples of 1–2 cm length were taken from duodenal, ileal and proximal colonic parts.
For histochemical analyses samples from each animal and intestinal region were embedded in
OCT compound (Tissue Tek; Sakura Finetek, Tokyo, Japan), frozen on dry ice and stored at
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-80°C. For gene expression analyses samples were submersed with RNAlater™ (Qiagen, Hilden,
Germany) overnight at 4°C, afterwards removed from the reagent and transferred to -80°C
until further use.
Immunohistochemistry
Immunohistochemistry was performed on 12 μm cryosections, small intestinal longitudinal
muscle-myenteric plexus (LMMP) strips, and gliospheres. Samples were fixed with 4% parafor-
maldehyde (PFA, AppliChem, Darmstadt, Germany). Blocking of unspecific binding sites was
achieved by incubating sections with 5% donkey serum (Sigma Aldrich, Germany) in 0.2% Tri-
ton-X 100 (Carl Roth, Karlsruhe, Germany). The following primary antibodies were diluted in
Lab Vision™ Antibody Diluent OP Quanto (Thermo Scientific, Dreieich, Germany) and incu-
bated overnight at 4°C: rabbit anti-GFAP (1:600; Dako, Hamburg, Germany), mouse anti-
HuC/D (clone 16A11, 1:100; Invitrogen, Germany), guinea pig anti-Sox10 (1:700, kindly pro-
vided by Prof. Wegner, Institute of Biochemistry, University Erlangen [29]), rabbit anti-p75
neurotrophin receptor (1:250, Promega, Mannheim, Germany), mouse anti-alpha smooth
muscle Actin (clone 1A4, 1:100, Abcam, Cambridge, United Kingdom) and rabbit anti-Vimen-
tin (clone EPR3776, 1:100, Abcam).
After washing, samples were incubated for 1 hour at room temperature with secondary anti-
bodies. Following washing, sections were mounted with Mowiol/1,4-diazabicyclo[2.2.2]octane
(DABCO) containing 0.1% 4',6-diamidino-2-phenylindole (DAPI, Carl Roth) and analyzed
using an inverse fluorescence microscope (Keyence, BZ-7000, Tokyo, Japan and Zeiss Axiovert
V.1, Jena, Germany).
For quantification of stained nuclei 10 representative images with 20x magnification were
taken per intestinal region (duodenum, ileum, proximal colon) of each sample (n = 5 per
group), counted in a blinded procedure and averaged. For pixel area measurements images
were taken accordingly. Fractional area measurements were performed of the intramuscular
GFAP-staining with ImageJ software (v1.38; National Institutes of Health, Bethesda, USA.)
with default settings.
RNA isolation and quantitative RT-PCR
Total RNA was isolated using the RNeasy Micro Kit according to the manufacturer’s instruc-
tions (Qiagen). 0.5 μg of total RNA was processed for reverse transcription using iScript™
cDNA Synthesis Kit, following the supplier’s protocol (Biorad, Muenchen, Germany). Quanti-
tative real-time PCR was performed in accordance to the MIQE-guidelines [30] with the
CFX96 Touch™ Real-Time PCR Detection System (Biorad) using the SsoFast™ EvaGreen1
Supermix (Biorad). Exon junction-spanning primer pairs were designed with Primer-BLAST
Software [31] (S1 Table). Quantitative real time-PCR was performed in duplicate with 0.4
pmol/μl of each primer and 0.5 μg cDNA at an annealing temperature of 60°C. Gene expres-
sion data were normalized to the reference genes β-actin (Actb) and 18S rRNA following the 2
(-Delta Delta C(T)) method described by Vandesompele [32] using the CFXManager software
(Biorad). The quality of amplified PCR products was proven by melting curve analysis and aga-
rose gel electrophoresis.
Laser capture microdissection
Laser capture microdissection (LCM) was performed on 12 μm cryosections mounted on UV-
light pretreated PEN-membrane covered slides (Carl Zeiss, Jena, Germany). Tissue sections
were shortly air-dried and stored at -80°C for LCM. Prior to LCM, cryosections were thawed
and stained with RNase-free 1% (w/v) cresyl violet acetate solution (Sigma) according to Carl
Enteric Glia Activation during Inflammation
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Zeiss MicroImaging PALM protocols. LCM was performed with the PALMMicroBeam Sys-
tem (Carl Zeiss MicroImaging, Bernried, Germany) according to the manufacturer’s instruc-
tions. Captured tissue segments were collected in AdhesiveCaps (Carl Zeiss) until a total tissue
area of on average 2.1x106 μm2 for myenteric and submucosal structures and of 2.8x106 μm2
for mucosal segments was excised. Segments were excised as directly adjacent oval shapes,
thereby the enteric myenteric and submucosal regions of the cryosections were collected. Prior
to RNA isolation lysis buffer was added and AdhesiveCaps were incubated upside down for 30
min at room temperature. RNA quality from randomized representative samples was assessed
in preliminary experiments using the Experion RNA HighSens Assay (Biorad) and yielded
good results in both the muscular and mucosal samples (average RIN 7.4).
Isolation and culture of GFAP-expressing enteric glia
Enteric glial cultures were propagated from FVB/hGFAP-EGFP transgenic mice expressing
green fluorescent protein under the control of the human GFAP-promotor [33]. At approxi-
mately postnatal day 7, all mice of the same litter were sacrificed by decapitation, small intes-
tines removed, screened for GFP-positivity, pooled and further processed as described before
[34]. Cells were resuspended in Dulbecco’s modified Eagle medium (DMEM)/F-12 medium
supplemented with Glutamax (Life Technologies, Darmstadt, Germany), penicillin (100 U mL-
1; PAA, Coelbe, Germany), streptomycin (100 mg mL-1; PAA), B27 without vitamin A (1:50;
Invitrogen), N2 (1:100; Invitrogen), sorted for GFP by flow cytometry and seeded onto culture
dishes coated with poly-ornithine (0.01%), fibronectin and laminin (both 1 μg cm-2; Sigma-
Aldrich). Epidermal growth factor (EGF; 40 ng mL-1; Peprotech, Hamburg, Germany) and
basic fibroblast growth factor (bFGF; 40 ng mL-1; Peprotech) were added daily and cells cul-
tured under hypoxic conditions (2% O2) in a humidified incubator at 37°C. Cell culture
medium was changed by 50% every 2–3 days.
For LPS-stimulation experiments, cells were passaged after 2 weeks and seeded on uncoated
plastic dishes to promote spheroid formation. Cells from each animal preparation (n = 3) were
split into two six well dishes, one stimulated with LPS (100 μg mL-1, from E. coli O26:B6,
Sigma Aldrich, potency 3 EU/ng). After 48 h, cell culture supernatants were collected for cyto-
kine measurements and cells processed for total RNA isolation.
Microarray analysis
Total RNA from gliospheres was extracted and RNA integrity (RIN> 7) assessed using the
Bioanalyzer technology (Agilent Technologies, Waldbronn, Germany) and further processed
on Illumina microarrays according to the manufacturer’s instructions (MouseRef-8v2.0
Expression BeadChip, Illumina, San Diego, USA). Data analysis was performed at the IZKF
core facility and Dept. of Bioinformatics of University Wuerzburg. Briefly, raw data was back-
ground-corrected (normexp method) and normalized (VSN method); microarray probes refer-
ring to unexpressed genes (detection p-value> 0.05 in all samples), known bad assay
performance or with no assigned genes were removed from the dataset. Moderated t-tests were
used for detection of differentially expressed genes. Analyses were performed in the R environ-
ment (Version 3.3.1) [35] with Bioconductor extension packages “vsn”, “made4”, “limma” and
“illuminaMousev1p1.db”. Enrichment analyses were performed with DAVID [36,37].
To visualize the differentially expressed genes and their association with Gene Ontology
(GO) terms [38,39], a color-coded Voronoi diagram was created [40]. We selected GO annota-
tion terms of the same high hierarchical level to achieve accumulation of a limited set of terms.
The calculation of the Delaunay triangulation and the subsequent calculation of Voronoi tes-
sellation was done in R by application of the deldir package (Version 0.1–9) [41].
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Data have been deposited in NCBI's Gene Expression Omnibus [42] and are accessible
through GEO Series accession number GSE78015 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE78015).
Comparative transcriptome analysis
The global transcriptional datasets generated in this study were compared with data from pre-
vious studies, deposited in public databases (NCBI Gene Expression Omnibus, GEO; S2 Table)
[42]. R/Bioconductor and the software package “virtualArray” were used to combine all data
into one dataset (virtual array) [35,43]. The resulting new array was exported and analyzed in
TM4MeV [44] and Archaeopteryx [45], which was further used to employ hierarchical cluster-
ing analysis to show similarities or differences to cells of related identity or other cells of inter-
est [46].
nCounter analysis
The nCounter technology (NanoString1 Technologies, Seattle, USA) was employed to validate
microarray data as described before [47]. A customized CodeSet was designed consisting of 60
genes identified in the microarray dataset as particularly interesting candidates, including 7 ref-
erence genes. The CodeSet probes were designed to bind at the same nucleotide position as the
Illumina probes used in the microarray assay (S3 Table). In order to yield sufficient amounts of
RNA, we pooled intestines of 5 separate litters of transgenic hGFAP-EGFP animals and mea-
sured in three technical replicates. Data acquisition and normalization was carried out using
the nSolver analysis software version 2.5 (NanoString1 Technologies).
Cytokine 20-Plex Bead Array
Cytokine and chemokine contents of gliosphere culture supernatants were quantified using the
multiplexed protein profiling Luminex1-method following the manufacturer’s protocol (Cyto-
kine Mouse 20-Plex Panel; Invitrogen, Karlsruhe, Germany). Analyses were done in triplicates
as previously described [48,49] (Luminex Corporation, Austin, USA) employing the StarSta-
tion software (ACS, Sheffield, UK).
Statistical analyses
Statistical analysis was performed with the nonparametric Mann-Whitney-U-Test or, if the cri-
terion of normal distribution was met, with univariate ANOVA. All statistical tests were per-
formed using SPSS (IBM). Results are given as mean ± standard deviation. The level of
statistical significance was set at p<0.05, indicated with asterisk (). Grading in significance is
indicated as follows: p<0.05, p<0.01, p<0.001. A p-value between 0.05 and 0.10 was
considered as moderate evidence for statistical significance and biological relevance and indi-
cated with a hash (#).
Results
Gene expression analysis of enteric glia in a hyperinflammation rat
model in vivo
The effects of a systemic inflammatory insult on the EGC network were analyzed in an in vivo
LPS-mediated hyperinflammation rat model. Glial marker expression was quantified on
mRNA and protein level in duodenal, ileal and colonic tissue segments. By quantitative PCR
analysis we found significantly increased levels of Gfap gene expression in the duodenal (6.8
±1.7-fold; p< 0.01) and colonic (5.5±1.6-fold; p< 0.01) segments of whole intestinal wall
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preparations 4 h after intravenous LPS injection compared to sham-treated controls (Fig 1A–
1C). This increase did not coincide with an overall glial marker expression increase, since
S100b expression in fact decreased after LPS treatment to 0.6-fold in duodenal and ileal, and to
0.4±0.1-fold (p< 0.01) in colonic segments. In contrast to the duodenum and colon, Gfap
expression in ileal segments showed no significant alteration, however the sham group already
reached relative expression values close to those observed in LPS-treated duodenal and colonic
samples.
Next, we aimed to analyze the region-specificity of LPS-responsive glia in our model. Thus,
we excised myenteric, submucosal and mucosal tissue segments via laser capture microdissec-
tion (Fig 2A) and performed subsequent qPCR analysis. Interestingly, the LPS-group revealed
a highly significant mRNA increase in the myenteric plexus of duodenal samples by 17.2
±5.2-fold (Fig 2B, p< 0.01), of ileal Gfap level by 3.5±0.8-fold (p< 0.01, Fig 2C) and of colonic
samples by 15.0±3.1-fold (Fig 2D, p< 0.01). As described before, we observed a concurrent
decrease in S100b expression, reaching significant values in the small intestine to the 0.4-fold in
the duodenum (p< 0.01) and to the 0.5-fold in the ileum (p< 0.05). Noteworthy, no signifi-
cant effects on Gfap or S100b expression were detected within the submucosal and whole
mucosal regions.
Despite the fact that significant protein changes after only 4 h of treatment might not be
expectable due to the delay of translation we included estimation of protein expression levels,
too. We quantified GFAP+ and Sox10+ cells within the muscular layer/myenteric plexus on
histological sections after immunohistochemistry (Fig 1B–1D). The cytoplasmic GFAP (Fig
1C) was quantified by pixel measurements and Sox10+ cells were determined by counting the
Sox10+/DAPI+ co-labeled cell nuclei (Fig 1D). We observed a statistical tendency for LPS-
induced reduction of Sox10+ glia by 38% in the duodenum (p< 0.10), in total numbers a
reduction from on average 5.8 Sox10+ nuclei counted per image to 3.6 Sox10+ nuclei. The
intramuscular GFAP quantification showed no significant alterations 4 h after LPS injection.
In analogy to the glial cell analysis, we also assessed neuronal mRNA transcript and protein
levels upon LPS-treatment (S1 Fig). However, neither pan-neuronal markers (Uchl1/PGP 9.5,
HuC/D) nor neuronal subtype markers such as for the cholinergic (Chat) and nitrinergic
(Nos1) subpopulations showed statistically significant alterations upon LPS stimulation. Simi-
lar to the glial Sox10 protein analysis we merely observed a statistical trend for decreased neu-
ronal cell number in the small intestine by 30% at most (S1B Fig). To summarize, 4 h after LPS
injection the overall neuronal and glial populations showed a tendency for reduced cell num-
bers, but the myenteric glial subpopulation showed a rapid activation and Gfap upregulation
was only detected on mRNA level within the experimental time frame.
Gene expression analysis of GFAP-glia after LPS-stimulation in vitro
In addition to the in vivo study we further investigated specific functions of the GFAP-express-
ing glial subpopulation in a prolonged acute inflammatory microenvironment in vitro. GFAP-
glia were isolated from LMMP-preparations from hGFAP-EGFP transgenic mice by flow
cytometry (Fig 3A–3C) and propagated as free-floating primary ‘gliospheres’ from the GFAP
+ population (Fig 3D–3F). After two weeks in culture, 60% of the cells within the gliospheres
were still strongly GFP-positive as confirmed by flow-cytometry (Fig 3F) and spheres stained
positive for GFAP (Fig 3G) and S100B (Fig 3H). Noteworthy, alpha smooth muscle actin-posi-
tive (Fig 3K) but no prominent vimentin-positive (Fig 3J) cells were detected.
Gliospheres were stimulated with LPS for 48 h and cell culture supernatants were analyzed
for secreted cytokines, chemokines and growth factors by multiplex protein profiling (Fig 4).
Thus, we detected elevated levels of several pro-inflammatory cytokines including interferon
Enteric Glia Activation during Inflammation
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Fig 1. Gfap gene expression upregulation in hyperinflamed intestinal rat tissue. (A) Quantitative PCR analysis of glial marker expression in whole
intestinal wall preparations from duodenal, ileal and colonic segments shows thatGfap gene expression but not S100b expression is upregulated in
hyperinflamed gut tissue. We found increases inGfap expression in duodenal segments by 6.8-fold and in colonic segments by 5.5-fold with a concurrent
decrease of S100b expression to the 0.4-fold. In ileal samples no significant changes were observed. Absolute normalized gene expression of Gfap (B) and
S100b (C) normalized to the reference genes (ΔΔCq). Means of LPS-treated samples (filled symbols) are indicated with lines, means of sham-treated
samples (empty symbols) are indicated with dashed lines. (D) Quantification of immunohistochemical stainings for intramuscular GFAP (E, representative
duodenal staining) and the glial transcription factor Sox10 (F, representative duodenal staining). 4 h after LPS injection we did not observe any significant
alterations on protein level. Counts of Sox10-positive nuclei in the myenteric plexus show a tendency to be reduced upon LPS treatment in the duodenum, on
average we counted 3.6 Sox10-positive nuclei per image in LPS-injected animals and 5.8 nuclei in sham-treated controls. Results (mean ± standard
deviation) are given as fold change relative to sham group set to 1, as indicated by the horizontal line, n = 5, # p < 0.10, ** p < 0.01, scale = 100 μm.
doi:10.1371/journal.pone.0151335.g001
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Fig 2. LPS-inducedGfap and S100b gene expression alterations are confined to the myenteric plexus. (A) Immunohistochemical staining of p75
neurotrophin receptor (p75NTR) indicating the position of myenteric and submucosal plexus structures within the tissue. (B-C) Cresylviolet-stained tissue
section showing exemplary myenteric, submucosal and mucosal tissue segments cut and catapulted for mRNA transcript level analysis (B) and sequential
excision of segments, here shown for the myenteric region (C). (D, F, H) Quantitative PCR analysis of laser-dissected myenteric, submucosal and mucosal
tissue segments of duodenal (D), ileal (F) and colonic (H) samples. In all intestinal regions the significant upregulation ofGfap up to the 17.2±5.2 fold change
in the duodenum and downregulation of S100b gene expression is confined to the myenteric plexus. Results (mean ± standard deviation) are given as fold
change relative to sham group set to 1. (E, G, I) Absolute normalized gene expression of Gfap (sqares) and S100b (circles) in duodenal (E), ileal (G) and
colonic (I) segments, plotted on a logarithmic scale. Means of LPS-treated samples (filled symbols) are indicated with lines, means of sham-treated samples
(empty symbols) are indicated with dashed lines. n = 3, *p<0.05, **p<0.01, scale = 100 μm.
doi:10.1371/journal.pone.0151335.g002
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Fig 3. GFAP-expressing glia sorted for EGFP reporter via flow cytometry and expanded in culture. (A) Endogenous GFP fluorescence and (B) overlay
with GFAP antibody staining in LMMP strips from transgenic postnatal day 7 mice visualizes that only cells within the plexus structures express GFP in
varying intensities. (C) Flow-cytometry analysis of the muscle tissue digest; the gated GFAP-GFP-positive population was sorted and cultured in vitro to
propagate gliospheres. (D) Brightfield and (E) fluorescence microscopy of gliospheres cultured for 2 weeks in vitro shows the formation of gliospheres with a
majority of cells expressing GFP. (F) Flow-cytometry analysis of glial culture 2 weeks after initial cell sorting reveals a strong GFP-positivity of about 60% of
the total cell population. Immunohistochemical stainings show that the major proportion within gliospheres consists of glial cells positive for GFAP (G) and
S100B (H) but spheres also contain cells expressing alpha smooth muscle actin (αSMA, Fig 3K) but are devoid of strongly vimentin-positive cells (J).
Scale = 100 μm.
doi:10.1371/journal.pone.0151335.g003
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(IFN)-γ, interleukin (IL)-1ß, IL-6 and the monocyte chemoattractant protein (MCP)-1. Only
IFN-γ increase reached high statistical significance, the other cytokines showed fluctuating
protein concentrations in the independent experiments but an overall increase in secreted lev-
els after LPS-stimulation. Other pro-inflammatory cytokines showed no increased secretion
such as IL-2, IL-12 and tumor necrosis factor (TNF)-α. Interestingly, we also detected elevated
levels of several anti-inflammatory cytokines including IL-4 and IL-5 suggesting a complex reg-
ulatory role of glia.
In the next step, we isolated total RNA from all samples and performed a whole transcrip-
tome analysis to detect overall LPS-induced modifications in gene expression profiles. Thus,
we identified 70 differentially expressed genes upon LPS-stimulation (S4 Table). Genes were
analyzed by annotations of the representative gene products according to biological functions
in the Gene Ontology (GO) database. From this bioinformatics resource significantly over-rep-
resented annotations of the gene products to GO-terms were derived, describing their cellular
compartment localization, molecular function and involvement in biological processes (Fig 5,
S5 Table). For the cellular localization, we found the significantly differentially expressed genes
annotated to terms describing the extracellular space (Fig 5A). Respectively, for the molecular
function we found over-represented associations to signaling processes such as cytokine and
chemokine activity (Fig 5B). For the biological processes the LPS-affected genes were predomi-
nantly annotated to immunologic processes, with the GO-term “immune response” showing
the most significant enrichment (enrichment by 7.7, p<0.001) (Fig 5C). However, the mere
enrichment of the annotation does not imply the degree of differential expression of the respec-
tive gene. To visualize the expression parameters of the genes associated to the “immune
response”-term, a color-coded voronoi diagram was created (Fig 5D). This diagram shows that
the “immune response”-associated genes includes those genes with the highest fold-change
increase in the dataset, such as chemokine (C-C motif) ligand 2 and 5 (Ccl2 and Ccl5).
For validation of our microarray data we chose the Nanostring nCounter assay and selected
60 genes, of which 14 ranked in the significantly differentially expressed gene set. Correlating
Fig 4. Signaling molecules secreted by GFAP-expressing glia. (A) Secretion of selected pro-inflammatory signaling molecules by untreated (-) and LPS-
challenged (+) gliospheres. Each data point represents an independent experiment, n = 3, ***p<0.001. (B) Tabular summary of all signaling molecules
measured.
doi:10.1371/journal.pone.0151335.g004
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Fig 5. Significantly upregulated glial genes upon LPS stimulation are enriched in immunologic processes. (A-C) Bar charts displaying significantly
enriched annotations of differentially expressed genes referring to cellular compartments (A), molecular functions (B) and biological processes (C). The level
of significance is given as logarithm (log10) of the p-value calculated using the Benjamini correction. Enrichment is given as the count of genes associated to
the respective term in the dataset relative to the expected count (Count/ExpCount). (D) Voronoi diagram displaying each significantly differentially expressed
gene. Genes are plotted based on their absolute expression level and the relative expression change in response to LPS treatment given as fold change. The
plotting area is segmented and a field is assigned to each gene, its size represents the unique character of the expression parameters. Yellow coloring
indicates association of a gene product to the GO-term “immune response”, which is enriched with the highest significance. Genes associated to this term
include some of those with the highest fold-change increase upon LPS-stimulation. Increased labeling font size indicates validation of expression with the
nCounter technology. (E) Spearman correlation of 60 genes analyzed with the Illumina microarray and the Nanostring nCounter technology. The Spearman
coefficient of 0.74 shows highly significant correlation (p<0.0001) of the results obtained with both technologies. Data points for the glial marker genesGfap
and S100b are highlighted in red.
doi:10.1371/journal.pone.0151335.g005
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the relative expression level changes upon LPS stimulation measured with both methods
revealed a high significance with a Spearman coefficient of 0.74 (Fig 5E, P< 0.0001).
Worth mentioning, neither Gfap nor S100b transcript levels did change significantly upon
LPS-stimulation in our analysis suggesting that the upregulation observed in vivo is mainly
caused by an initially GFAP-negative cell population (highlighted in Fig 5E).
Finally, we extended our analysis to compare the transcriptome data with different tissues
and cell types published in the Gene Expression Omnibus (GEO) database [42]. This compara-
tive meta-analysis (Fig 6A) showed that directly sorted intestinal GFAP-glia cluster together
with central and peripheral nerve cell types and differ from those GFAP-glia expanded in vitro
for several weeks. The latter have a much closer transcriptomic resemblance to mesenchymal
cell types. Another interesting aspect is that a defined comparison of glial-specific data sets (Fig
6B) revealed the high transcriptomic similarity between enteric GFAP-glia in vivo and CNS
astrocytes expanded in vitro. In contrast, enteric GFAP-glia expanded in vitro showed greater
resemblance to cells isolated from peripheral sciatic nerves. A further intriguing aspect of this
analysis is that LPS-stimulation of astrocytes and microglia has a profound impact on their
transcriptomic profile, whereas the impact on enteric GFAP-glia seems relatively moderate.
Discussion
Enteric glia are known to resemble CNS astrocytes in their reactivity to an inflammatory envi-
ronment. However, such findings have originated mostly from studies on local mucosal inflam-
mation, either from a chronic disease manifestation as in IBD patients or from acute
experimental mucosal manipulation. Little is known about the responsiveness of glia outside the
mucosa in the ganglionated structures, which constitute the majority of the EGC network. To
study the early response of the entire EGC network to intestinal inflammation not limited to the
mucosa, we performed an acute systemic hyperinflammation study in vivo induced by intrave-
nous injection of LPS, mimicking the pathological situation observed in postoperative SIRS.
4 h after induction of a systemic inflammation by intravenous LPS-injection we analyzed
duodenal, ileal and colonic tissue segments for glial marker expression. We found a tremen-
dous upregulation of GfapmRNA transcript levels. Interestingly, as revealed by LCM, Gfap
expression regulation was confined to the muscular layer harboring the myenteric plexus.
Myenteric glia have recently gained attention in the context of inflammation-induced
impairment of gastrointestinal (GI) motility [26]. Stoffels et al. identified interleukin-1 receptor
(Il-1R1) signaling as essential for surgery-induced inflammation and resulting impaired con-
tractility. The group identified GFAP-expressing myenteric glia as the predominant IL-
1R1-expressing resident intestinal cell type, highlighting the potential of GFAP-glia to shape
intestinal inflammation. Our findings support this concept of myenteric GFAP-glia as fast-
responding, reactive cell types in acute inflammation in vivo. Even though a differential suscep-
tibility of EGCs in different plexus structures is an appealing interpretation of our data, it is
also plausible that intravenous LPS-injection led to a differing distribution of LPS within the
tissue and hence a differing activation of EGCs.
Interestingly, we observed different manifestations of LPS-dependent myenteric Gfap
expression upregulation along the intestinal proximal-distal axis, being less pronounced in ileal
samples. This resulted from already high ileal expression levels in the sham group, which ran-
ged close to those in the LPS-treated duodenal and colonic samples and suggests further factors
affecting Gfap expression levels. Indeed, our surgical procedure offers a potential explanation:
Besides LPS-injection we performed laparotomy and the GI tract was partially exposed. Mild
manipulation of the intestine following laparotomy can already be sufficient to induce inflam-
matory reactions and impaired motility as compared to laparotomy alone [50,51]. Therefore, it
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Fig 6. Comparative meta-analyses of multiple GSE datasets reveal genetic similarities among different tissue. (A) and (B) display complete
dendrograms, the length along the line connecting two datasets indicates the degree of similarity; the shorter the distance of connecting lines, the more
similar these datasets are. For better legibility the list of datasets are enlarged right of the dendrogram overview. (A) Comparative analysis of gene
expression profiles of GFAP-expressing glia and profiles of different tissues/cell types reveals a high similarity of GFAP-glia in vivo to CNS and PNS nerve
cell types and a much lower similarity to GFAP-glia expanded in vitro. Gene expression profiles of the latter show similarities to mesenchymal cell types. (B)
Hierarchical clustering of glial-specific GSE datasets to show similarities of enteric GFAP-glia to CNS and PNS glia including LPS-challenged cells.
Comparative analysis reveals high similarity of GFAP-glia in vivo to astrocytes in vivo. If cultured in vitro, the GFAP-glia genetic profile has higher similarity to
PNS sciatic nerve cells and CNSmicroglia. LPS stimulation leads to severe alterations in gene expression profiles of CNS astrocytes and microglia, which
seems not the case for EGCs.
doi:10.1371/journal.pone.0151335.g006
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is possible that the surgical procedure itself also contributes to an altered Gfap expression inde-
pendent of LPS-stimulation. We consider this “two-hit”-character of our hyperinflammation
model to mimic the clinical situation well, since patients become septic usually following a first
hit, such as an ileus after severe surgery. Support for a potentially differing susceptibility of ileal
GFAP-EGC to external stimuli come from animal models, in which immune-mediated abla-
tion of GFAP-EGCs led to fatal inflammation specifically of the ileum, not the duodenum or
proximal colon [52]. Furthermore, different intestinal segments along the proximal-distal axis
as well as in different plexus layers vary in glial subtype composition and density [29]. Correlat-
ing the plexus composition to the physiological responsiveness of the tissue area will be highly
interesting aspect of EGC physiology.
The varying degrees of Gfap expression increase we observed were accompanied by a signifi-
cant decrease in S100b gene expression levels in duodenal and ileal myenteric samples as well
as colonic whole gut wall samples. Previously, the expression and secretion of the glial-specific
enteric S100B has been described to correlate with the gut inflammatory status [14,53,54].
Increased levels of S100B protein are known in biopsies from UC-patients [54] and in vitro
upon inflammatory stimulation. Mechanistically, secreted S100B induces an increase in glial
inducible nitric oxide synthase (iNOS) and thereby leads to elevated secretion of nitric oxide
(NO), a prominent pro-inflammatory mediator [11]. At first, our observations in vivo and the
lack of S100b upregulation in the LPS stimulated gliospheres in vitro seem to be in conflict with
the data obtained by Cirillo et al. However, a possible explanation lies in the nature of inflam-
matory stimulus: Cirillo et al. incubated tissue biopsies [14] and purified glial cultures [11]
with a combination of LPS and interferon-gamma (IFN-γ) and describe that neither LPS nor
IFN-γ alone had an effect on iNOS expression level, implying also a lack of effect of LPS alone
on S100B expression and secretion. It can be followed that the LPS-mediated hyperinflamma-
tion model we employed elicits an activation of glia regarding their GFAP-status but this acti-
vated glial phenotype does not necessarily correlate to glial alterations concerning S100B
secretion observed in IBD.
These in vivo findings on Gfap upregulation do not imply whether it affected cells that had
been GFAP+ before the stimulation. It is also possible that GFAP- cells were induced to express
Gfap upon LPS-stimulation, given the significant plasticity of GFAP expression in individual
EGCs in vitro and in vivo [5,19]. To focus on the inflammation-induced molecular alterations
specifically in the GFAP-expressing glial subpopulation, a transgenic hGFAP-EGFP mouse
strain and established protocols for free-floating murine neurosphere-like bodies [34] were
adapted to generate primary, purified “gliospheres” from flow cytometry-sorted GFAP+ glia.
The GFAP+ population accounted for 4% of the total LMMP digest and could be propagated
to form gliospheres that showed strong immunostaining for S100B and the intermediate fila-
ment GFAP but not Vimentin after prolonged in vitro culture. Vimentin and GFAP are
described to be developmentally regulated in reverse manner, in immature glial cells GFAP
expression is low and Vimentin is strongly expressed, whereas mature glia express high levels
of GFAP and reduced levels of Vimentin [7]. Due to the high plasticity of GFAP expression
40% of an initially purified GFP-positive culture lost strong GFP-positivity. Interestingly, glio-
spheres contained αSMA-expressing cells. Since gliospheres were propagated from an initially
purified GFP-positive population, an overgrowing contamination of the culture with non-glial
muscle cells to such an extent seems unlikely within 2 weeks in vitro. This finding might rather
be explained by the dependence of the glial cell phenotype on cues from their native microenvi-
ronment and consequently dedifferentiation of enteric glia in culture [55]. It is documented
that enteric glia lose morphological and molecular characteristics ex vivo [7] and acquire capa-
bilities not observed in vivo such as a neurogenic potential, or giving rise to αSMA-positive
muscle cells [16,56]. In line with this, multipotent nestin-positive neural crest cells isolated
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from postnatal murine intestines were found to express both αSMA and GFAP after 1 day in
culture and can subsequently dedifferentiate to muscle cells [57].
In a next step, we analyzed the secretion of inflammatory mediators by LPS-stimulated glio-
spheres. To determine a suitable time frame for the LPS stimulation we followed studies on
cytokine secretion by stimulated CNS astrocytes in vitro, which measured strong effects after
24–48 h of stimulation [58,59]. Further, studies on EGC had shown that EGC-activation by
LPS and subsequent secretion of EGC-derived growth factors or cytokines peaks between 24–
48 h [19,13]. Indeed, we found that the primary GFAP+-glia derived gliospheres secreted dif-
ferent inflammatory cytokines upon extended LPS-stimulation such as IL-1β, IL-6, MCP-1 and
IFN-γ, which was also described by studies conducted on the overall glial population [19,26].
Knowledge on distinct, subpopulation-specific glial functions is scarce. Our dataset indicates
that the well-known ability of EGCs to release inflammatory cytokines in response to exoge-
nous stimuli can be exerted by those cells derived from the GFAP+ subpopulation.
To unravel general molecular pathways as response to acute inflammation we performed a
high-throughput transcriptomic study. LPS-treated enteric gliospheres showed 70 significantly
differently expressed genes, often associated with immune responses, a signature also observed
in reactive astrocytes of the CNS. Thus, the gene product of Lcn-2, Lipocalin-2, the gene with
the highest fold change increase in our dataset, plays a role in the morphological and functional
fate of reactive astrocytes, e.g. by inducing GFAP expression [60]. The gene products of Ccl2
and Ccl5, also known as MCP-1 and RANTES, are described to be produced by β-amyloid pep-
tide-challenged astrocytes and act as microglial and macrophage chemoattractants in vitro
[61]. Interestingly, we observed no significant upregulation of Gfap, S100b or other glial mark-
ers such as glial cell line-derived neurotrophic factor (GDNF), potentially indicating that puri-
fied primary GFAP-positive cells do not further upregulate synthesis of GDNF and S100B and
that expression of these factors is induced in GFAP-low expressing cells during cell activation.
Taken together, these data indicate that GFAP-EGCs are reactive to the acute LPS-stimulus in
vitro and acquire a phenotype reminiscent of reactive CNS astrocytes.
Finally, our meta-analysis added more information to the aspect of analogy between EGCs
and astrocytes. EGCs freshly isolated from mice showed close resemblance to astrocytes. Inter-
estingly, while LPS treatment led to a dramatic change in gene expression profiles of CNS
astrocytes and microglia, EGCs transcriptomes shifted at a much smaller extend. This might
have a biological background since EGCs could be less sensitive to LPS due to the physiological
exposure to bacterial components in the gut. Another possible explanation lies in the shift in
transcriptomic profiles, which we observed after prolonged in vitro culture. Thus, the expanded
gliospheres showed a molecular drift to mesenchymal cell entities, which correlates with the
immunopositivity of gliospheres for αSMA and is likely caused by transdifferentiation of EGCs
[16,57,62] or a reconstitution of an initially negligible muscle cell contamination in the cell-
sorted culture. Another interesting aspect is that Rao et al. recently described a transcriptomic
resemblance of Proteolipid Protein 1 (PLP1)+ EGCs to peripheral Schwann cells and only lim-
ited similarity to astrocytes [63]. This difference might be due to the low co-expression of PLP1
and GFAP by EGCs between 35–54% [63] and indicate the diversity of glial subpopulations.
Taken together, our data indicate that EGCs are responsive to an inflammatory environ-
ment within a short time frame. Administering LPS intravenously leads to a specific response
of myenteric EGCs, adding new information to previous studies focusing on mucosal glia acti-
vation after epithelial barrier breakdown. It will be interesting to investigate if the transcrip-
tomic shift in favor of immunomodulatory capacities observed in vitro can be verified in vivo
and if EGCs indeed can modulate the onset and progression of inflammation. In the future,
this knowledge might help us to better understand inflammatory disease progression and even-
tually aid to novel therapeutic treatment options.
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Supporting Information
S1 Fig. Neuronal cells are not affected 4 h after LPS injection. (A) Quantitative PCR analysis
of neuronal marker expression in whole intestinal wall preparations from duodenal, ileal and
colonic segments. No inflammation-induced alterations are observed in mRNA expression lev-
els of the overall neuronal marker Uchl1 (PGP 9.5) or cholinergic (Chat) and nitrinergic (Nos1)
subpopulations. (B) Hu-positive neuronal nuclei (C) numbers in the myenteric plexus are nei-
ther significantly affected, we only observe a tendency for reduced numbers in ileal segments.
Results (mean ± standard deviation) are expressed as fold change relative to sham group set to
1, as indicated by the horizontal line. n = 3–5, # p< 0.10, scale = 100 μm.
(TIF)
S1 Table. qPCR primers employed in this study.
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S2 Table. Gene Ontology datasets employed in the meta-analysis.
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S3 Table. Nanostring nCounter Codeset probes. Probes were designed to target the same
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